Company Filing History:
Years Active: 2023-2024
Title: Klaus Hellerbrand: Innovator in Pharmaceutical Formulations
Introduction
Klaus Hellerbrand is a notable inventor based in Martinsried, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative liquid formulations. With a total of 3 patents to his name, Hellerbrand's work has the potential to impact medical treatments significantly.
Latest Patents
Hellerbrand's latest patents include a liquid pharmaceutical formulation that is stable at room temperature and essentially free of water. This formulation comprises at least one easily degradable active pharmaceutical ingredient, a pharmaceutically acceptable organic solvent, and a pharmaceutically acceptable alkaline earth metal salt, which can be utilized in various medical applications. Another significant patent is for a pharmaceutical composition comprising selexipag, which includes specific compounds and is designed for intravenous administration. This invention also details processes for preparing these compositions, aimed at treating diseases related to IP receptors.
Career Highlights
Throughout his career, Klaus Hellerbrand has worked with prominent companies in the pharmaceutical industry, including Project Pharmaceutics GmbH and Actelion Pharmaceuticals Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical formulations and contribute to innovative solutions in medicine.
Collaborations
Hellerbrand has collaborated with notable colleagues such as Andreas Schuetz and Alexandra Schlicker-Spain. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented formulations.
Conclusion
Klaus Hellerbrand's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of formulation chemistry and its applications in healthcare. Hellerbrand's work continues to pave the way for new therapeutic options in the pharmaceutical industry.